13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 4 managers

Reported value

$2.1M

Holders

4

+0 new · −0 exited

Holders’ est. mark

$46.3K

Price effect on 3 books still in the name

Largest holder

$1.71M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC121.2K$1.71M$40.3KAdded$49.3K
Henshaw Capital LLC10.2K$369K$5.7KAdded$5.7K
Leonteq Securities AG520$18.8K$292Added$292

Positions as of Q1 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.